archetype (adl_version=1.4)
	openEHR-EHR-EVALUATION.dutch_lipid_clinic_network_score.v1

concept
	[at0000]	-- Dutch lipid clinic network (DLCN) score
language
	original_language = <[ISO_639-1::en]>
	translations = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			author = <
				["name"] = <"Dennis Forslund">
				["organisation"] = <"Cambio Healthcare Systems">
			>
		>
	>
description
	original_author = <
		["name"] = <"Eneimi Allwell-Brown">
		["email"] = <"models@cambiocds.com">
		["organisation"] = <"Cambio Healthcare Systems">
		["date"] = <"2017-02-23">
	>
	details = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			purpose = <"Att understödja diagnostik vid misstanke om familiär hyperkolesterolemi (FH) hos vuxna.">
			use = <"Utvärdering av poäng genererad i enlighet med DLCN, i syfte att understödja diagnostik av familjär hyperkolesterolemi (FH).
DLCN > 8p = definitiv FH
DLCN 6-8p = sannolik FH
DLCN 3-5p = möjlig FH
DLCN < 3p = FH osannolikt.

DLCN >5p och framförallt förekomst av xantom och/eller högt kolesterol i kombination med familjehistorik av kranskärlssjukdom bör föranleda genetisk utredning och remiss till lipidspecialist.
Genetisk utredning bör även erbjudas förstagradssläktingar till individer med bekräftade mutationer.

Rådata för DLCN registeras med separat arketyp: openEHR-EHR-OBSERVATION.dutch_lipid_clinic_network_score.v1">
			keywords = <"familjär hyperkolesterolemi", "FH", "xantom", "LDL", "kolesterol">
			misuse = <"">
			copyright = <"© Cambio Healthcare Systems">
		>
		["en"] = <
			language = <[ISO_639-1::en]>
			purpose = <"To assess the DLCN score and aid diagnosis of heterozygous Familial Hypercholesterolaemia (FH) in adults.">
			use = <"To record the assessment of DLCN score and aid diagnosis of FH.
DLCN score > 8 = definite FH
DLCN score 6-8 = probable FH
DLCN score 3-5 = possible FH
DLCN score < 3 = unlikely FH.
Molecular genetic testing and referral to a lipid specialist is strongly recommended in individuals with DLCN score > 5 and particularly those with xanthoma and/or high cholesterol plus a family history of premature coronary heart disease. Molecular genetic testing should also be offered to all first degree relatives of individuals with a confirmed causative mutation. 

DLCN score data is recorded in a separate observation archetype: openEHR-EHR-OBSERVATION.dutch_lipid_clinic_network_score.v1">
			keywords = <"familial hypercholesterolemia", "FH", "xanthoma", "arcus", "LDL-cholesterol", "genetic testing", "coronary heart disease">
			misuse = <"">
			copyright = <"© Cambio Healthcare Systems">
		>
	>
	lifecycle_state = <"AuthorDraft">
	other_contributors = <>
	other_details = <
		["references"] = <"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. European heart journal. 2013 Dec 1;34(45):3478-90.

Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Bmj. 2003 Jun 26;326(7404):1423.

The European Atherosclerosis Society. Familial Hypercholesterolaemia Score. Available from: https://www.fhscore.eu/#/about#section3">
		["MD5-CAM-1.0.1"] = <"7D2381286C6B7B31BEB0762009540231">
	>

definition
	EVALUATION[at0000] matches {	-- Dutch lipid clinic network (DLCN) score
		data matches {
			ITEM_TREE[at0001] matches {	-- Tree
				items cardinality matches {0..*; unordered} matches {
					ELEMENT[at0002] occurrences matches {0..1} matches {	-- DLCN score assessment
						value matches {
							DV_CODED_TEXT matches {
								defining_code matches {
									[local::
									at0003, 	-- Definite familial hypercholesterolemia (FH)
									at0004, 	-- Probable familial hypercholesterolemia (FH)
									at0005, 	-- Possible familial hypercholesterolemia (FH)
									at0006]	-- Unlikely familial hypercholesterolemia (FH)
								}
							}
						}
					}
					ELEMENT[at0007] occurrences matches {0..1} matches {	-- Comment
						value matches {
							DV_TEXT matches {*}
						}
					}
				}
			}
		}
	}

ontology
	term_definitions = <
		["en"] = <
			items = <
				["at0000"] = <
					text = <"Dutch lipid clinic network (DLCN) score">
					description = <"The Dutch Lipid Clinic Network (DLCN) score is derived from the responses to a set of 10 clinical and laboratory-based questions recommended by the European Atherosclerosis Society (EAS) for aiding the diagnosis of heterozygous Familial Hypercholesterolaemia (FH) in adults. The criteria fall into five categories: family history (2 points), clinical history (2 points), physical examination findings (6 points), pre-treatment LDL cholesterol level (8 points) and presence of causative mutation on DNA analysis (8 points); minimum score = 0 and maximum score = 26. DLCN score >8 is ‘definite FH’, score 6 - 8 is ‘probable FH', score 3 - 5 is ‘possible FH’ and score <3 is ‘unlikely FH’.">
				>
				["at0001"] = <
					text = <"Tree">
					description = <"@ internal @">
				>
				["at0002"] = <
					text = <"DLCN score assessment">
					description = <"Assessment of the DLCN score and probability of a diagnosis of familial hypercholesterolemia.">
				>
				["at0003"] = <
					text = <"Definite familial hypercholesterolemia (FH)">
					description = <"DLCN score > 8">
				>
				["at0004"] = <
					text = <"Probable familial hypercholesterolemia (FH)">
					description = <"DLCN score 6-8">
				>
				["at0005"] = <
					text = <"Possible familial hypercholesterolemia (FH)">
					description = <"DLCN score 3-5">
				>
				["at0006"] = <
					text = <"Unlikely familial hypercholesterolemia (FH)">
					description = <"DLCN score < 3">
				>
				["at0007"] = <
					text = <"Comment">
					description = <"Any additional information about this recording.">
				>
			>
		>
		["sv"] = <
			items = <
				["at0000"] = <
					text = <"Dutch Lipid Clinic Network (DLCN) - utvärdering">
					description = <"Dutch Lipid Clinic Networks (DLCN) kriterier baseras på tio frågor rekommenderade av European Atherosclerosis Society (EAS) i syfte att understödja diagnostik vid misstanke om familiär hyperkolesterolemi (FH) hos vuxna. Frågorna delas upp i fem områden: familjehistorik (förstagradssläkting som i tidig ålder drabbats av kranskärlssjukdom, senxantom, arcus senilis eller LDL-kolesterol >95:e percentilen); sjukdomshistoria (i tidig ålder insjuknat i hjärtkärlsjukdom, cerebral eller perifer kärlsjukdom); undersökningsfynd (senxanton eller arcus senilis); provsvar (LDL-kolesterol); och molekylär testning (DNA-analys). Vardera kriterium tilldelas viktad poäng, och maximal poäng uppgår till 26p. DLCN >8p definieras som ”Definitiv FH”, 6-8p som ”Sannolik FH”, 3-5p som ”möjlig FH” och 0-2p som ”FH osannolikt”. ">
				>
				["at0001"] = <
					text = <"*Tree(en)">
					description = <"*@ internal @(en)">
				>
				["at0002"] = <
					text = <"DLCN - resultat">
					description = <"Utvärdering av poäng genererad i enlighet med Dutch Lipid Clinic Network (DLCN).">
				>
				["at0003"] = <
					text = <"Definitiv familjär hyperkolesterolemi">
					description = <"DLCN > 8p">
				>
				["at0004"] = <
					text = <"Sannolik familjär hyperkolesterolemi">
					description = <"DLCN 6-8p">
				>
				["at0005"] = <
					text = <"Möjlig familjär hyperkolesterolemi">
					description = <"DLCN 3-5p">
				>
				["at0006"] = <
					text = <"Familjär hyperkolesterolemi osannolikt">
					description = <"DLCN < 3p">
				>
				["at0007"] = <
					text = <"Kommentar">
					description = <"Ev. tillägg.">
				>
			>
		>
	>
